Retatrutide, developed by Soma Chems , is gaining considerable attention as a innovative method for weight control . This innovative drug integrates the properties of a GLP-1 receptor activator and a GIP receptor stimulant, aiming to not only promote reduced body fat but also target underlying metabolic conditions . Early clinical studies have indi